2018/06/05（火）
Pitch 1-8 : Yasumichi Hitoshi, Thyas Co. Ltd.
Dr. Hitoshi will pitch in Pitch Session 1!
等氏はPitch Session 1に登壇予定！
| Pitch Title |
Fighting Cancer with Nobel Prize-winning iPS Cell Technology |
| Speaker |
Yasumichi Hitoshi President & CEO, Thyas Co. Ltd. 等 泰道 氏 |
| Speaker Profile | Dr. Hitoshi obtained a MD degree and acquired PhD in immunology. He is familiar with immunology, cytokine signaling, immuno-oncology, cancer metabolism, metabolic diseases, and retroviral transduction systems. He has >15 year experience with heading oncology and metabolism researches (Target identification and validation, preclinical development of small molecule therapeutics) as a research director. He was involved in the IND filling process of multiple drugs. |
Notice
HVC KYOTO 2018 will be held on July 3rd 2018!
Click here for the program.
To attend the event, please fill out the form from here!
ご案内
HVC KYOTO 2018は2018/7/3に開催いたします。
当日のプログラムは こちら をご覧ください。
HVC KYOTO 2018への参加お申し込みは こちら から。
